TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Other Assets, Current in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Teva Pharmaceutical Industries Ltd quarterly Other Assets, Current history and growth rate from Q1 2010 to Q3 2024.
  • Teva Pharmaceutical Industries Ltd Other Assets, Current for the quarter ending September 30, 2024 was $445M, a 14.4% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $445M -$75M -14.4% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $517M +$31M +6.38% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $495M -$47M -8.67% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $504M -$45M -8.2% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $520M -$59M -10.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $486M -$32M -6.18% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $542M -$391M -41.9% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $549M -$416M -43.1% Dec 31, 2022 10-K 2024-02-12
Q3 2022 $579M -$226M -28.1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $518M +$34M +7.03% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $933M +$281M +43.1% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $965M +$255M +35.9% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $805M +$382M +90.3% Sep 30, 2021 10-Q 2021-10-27
Q2 2021 $484M +$36M +8.04% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $652M +$114M +21.2% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $710M +$276M +63.6% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $423M +$7M +1.68% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $448M +$11M +2.52% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $538M +$100M +22.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $434M -$34M -7.27% Dec 31, 2019 10-K 2021-02-10
Q3 2019 $416M -$67M -13.9% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $437M -$248M -36.2% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $438M -$274M -38.5% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $468M -$233M -33.2% Dec 31, 2018 10-K 2020-02-21
Q3 2018 $483M Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $685M Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $712M Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $701M Dec 31, 2017 10-K 2019-02-19
Q3 2010 $1.81B Sep 30, 2010 6-K 2010-11-02
Q2 2010 $1.5B Jun 30, 2010 6-K 2010-07-27
Q1 2010 $1.54B Mar 31, 2010 6-K 2010-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.